The global newborn screening market is poised for promising growth in the short term, driven by a surge in demand and advancements in healthcare technologies. A recent report has unveiled insights into how the markets growth trajectory is expected to unfold in the coming years.
Increasing Prevalence of Disorders in Newborns to Fuel Growth
Neonatal screening, commonly known as the heel prick test or newborn screening test, has become a crucial blood test for newborn babies to detect genetic, metabolic, blood, or other disorders that may not be immediately apparent after birth. The demand for newborn screening is on the rise because these tests can diagnose rare yet severe health disorders even before visible symptoms manifest. Early diagnosis and timely treatment can significantly mitigate or prevent the lifelong effects of these disorders, ensuring the well-being of newborns.
Newborn screening covers a range of tests, including those for hormone disorders, metabolic disorders, hemoglobin conditions, immune system disorders, and several rare but serious conditions such as cystic fibrosis, Pompe disease, X-linked adrenoleukodystrophy, and spinal muscular atrophy. The sustained demand for screening for these conditions is expected to keep the newborn screening market on an upward trajectory.
Proliferating Prevalence of Congenital Heart Abnormalities
Recent years have witnessed a rise in infant illnesses, prompting healthcare professionals to emphasize the need for more sophisticated screening tools. Severe congenital heart abnormalities, including conditions like tricuspid pulmonary atresia, have been on the rise. According to the Centers for Disease Control and Prevention (CDC), approximately 40,000 newborns in the United States, accounting for 1 percent of all births, are affected by congenital cardiac abnormalities annually. Timely detection of these conditions is critical, as infants with severe heart diseases often require surgery or other interventions within their first year of life.
Impact of COVID-19 on Newborn Screening
The COVID-19 pandemic has also played a significant role in catalyzing the growth of the newborn screening market. The enormous demand for dried blood spot (DBS) newborn screening tests during the pandemic has led to the development of new screening tests. Companies like PerkinElmer Inc. introduced DBS-based tests for SARS-CoV-2 IgG, capable of processing up to 5,000 samples per day. This development has influenced the overall performance of the newborn screening market.
Expanding Infant Population in North America
North America has emerged as a key region in the global newborn screening market. The regions newborn screening industry is witnessing rapid growth due to the expanding need for advanced screening systems and the increasing incidence rates of diseases in neonates. Every newborn in the United States undergoes post-birth examination through the study of diagnostic markers in blood spots collected on filter paper on their second day of life. The well-established healthcare infrastructure in the region is expected to further fuel market growth.
Competitive Landscape
Prominent players in the newborn screening market include Natus Medical, PerkinElmer, Demant A/S, Danaher Corporation, Chromsystems Instruments & Chemicals GmbH, Bio-Rad Laboratories, Medtronic, Baebies, Trivitron Healthcare, and Recipe Chemicals+Instruments. The market is witnessing continuous innovation, with companies introducing new screening tests and technologies to meet the growing demand for newborn screening.
Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) https://www.fairfieldmarketresearch.com/report/newborn-screening-market
Visit Our Blogs:
About Us
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.
Contact
Fairfield Market Research
London, UK
UK +44 (0)20 30025888
USA (Toll-free) +1 (844) 3829746
Web: https://www.fairfieldmarketresearch.com/
Email: sales@fairfieldmarketresearch.com
This press release first seen on Brilad
COMTEX_442320024/2840/2023-10-23T08:21:12